US2015157643A1PendingUtilityA1
Method for post coital contraception in overweight or obese female subjects using ulipristal acetate
Est. expiryFeb 1, 2030(~3.6 yrs left)· nominal 20-yr term from priority
A61P 15/18A61K 31/57
41
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention provides a method for providing post coital contraception in a female subject, comprising providing the subject with a therapeutically effective amount of ulipristal acetate, wherein the female subject is overweight or obese.
Claims
exact text as granted — not AI-modified1 . A method for providing post coital contraception in a female subject, comprising providing the subject with a therapeutically effective amount of ulipristal acetate, wherein the female subject is overweight or obese.
2 . The method of claim 1 wherein the female subject has a body mass index (BMI) above about 25.
3 . The method of claim 1 , wherein the female subject has a body mass index (BMI) between about 25 and about 35.
4 . The method of claim 1 , wherein the female subject has a body mass index (BMI) between about 25 and about 30.
5 . The method of claim 1 , wherein the female subject has a body mass index (BMI) between about 30 and about 35.
6 . The method of claim 1 , wherein the female subject has a body mass index (BMI) above about 35.
7 . The method of claim 1 , wherein post coital contraception is provided within about 72 hours after unprotected intercourse.
8 . The method of claim 1 , wherein post coital contraception is provided within about 120 hours after unprotected intercourse.
9 . The method of claim 1 , wherein the post coital contraception is emergency contraception.
10 . The method of claim 1 , wherein the ulipristal acetate is administered in an oral dosage form.
11 . The method of claim 10 , wherein the oral dosage form is a tablet.
12 . The method of claim 1 wherein the dosage form comprises about 30 mg ulipristal acetate.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.